Dartmouth Middle Meningeal Embolization Trial (DaMMET)

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

January 11, 2024

Study Completion Date

January 11, 2024

Conditions
Chronic Subdural HematomaSubdural Hematoma
Interventions
PROCEDURE

Embolization of the Middle Meningeal Artery

Using established endovascular techniques and materials patient will have a diagnostic catheter based angiogram performed on the side(s) of the brain where the subdural hematoma is present. After verifying the vascular anatomy to ensure safety of the procedure the Middle Meningeal Artery will be embolized.

PROCEDURE

Standard of care including possible surgical evacuation of subdural hematoma

Standard of care could include observation or intervention including surgical drainage of subdural hematoma by bedside drain, Subdural Evacuating Port System (SEPS), burr hole or craniotomy

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT04270955 - Dartmouth Middle Meningeal Embolization Trial (DaMMET) | Biotech Hunter | Biotech Hunter